Target Name: TERC
NCBI ID: G7012
Other Name(s): DKCA1 | TRC3 | telomerase RNA component | hTR | TR | TER | Telomerase RNA component | PFBMFT2 | SCARNA19

TERC: A Potential Drug Target for Various Diseases

TERC (Tissue-Specific Enhanced Receiver Cell) is a protein that is expressed in various tissues of the human body, including the brain, heart, and kidneys. It is a type of transmembrane protein that is characterized by the presence of a extracellular domain, a transmembrane region, and an intracellular domain.

One of the unique features of TERC is its ability to interact with various signaling molecules, including G protein-coupled receptors (GPCRs) and ion channels. This interaction with these molecules makes TERC an attractive target for drug development.

In recent years, several studies have identified TERC as a potential drug target for various diseases, including heart failure, hypertension, and diabetes. These studies have shown that TERC is involved in the regulation of various physiological processes, including cardiac function, blood pressure, and glucose metabolism.

One of the potential benefits of TERC as a drug target is its ability to localize to specific tissues and organs, which can reduce the risk of unintended side effects. This is especially important for drugs that are designed to modulate gene expression or cellular behavior. By selectively targeting TERC, researchers can minimize the impact on other tissues and organs.

Another potential benefit of TERC as a drug target is its role in the regulation of cellular processes that are important for human health. For example, TERC has been shown to be involved in the regulation of cardiac contractility and blood pressure. This makes it an attractive target for drugs that are designed to treat conditions such as heart failure or hypertension.

In addition to its potential therapeutic applications, TERC is also a valuable biomarker for the diagnosis and prognosis of various diseases. For example, TERC has been shown to be elevated in the hearts of patients with heart failure, which makes it an potential diagnostic marker for this condition. Similarly, TERC has been shown to be decreased in the hearts of patients with hypertension, which makes it an potential biomarker for this condition.

Overall, TERC is a protein that is expressed in various tissues of the human body and has been shown to be involved in the regulation of various physiological processes. As a result, it is an attractive target for drug development for a variety of conditions. Further research is needed to fully understand the role of TERC in human health and to develop effective treatments.

Protein Name: Telomerase RNA Component

More Common Targets

TERF1 | TERF1P3 | TERF2 | TERF2IP | TERLR1 | TERT | TES | TESC | TESK1 | TESK2 | TESMIN | TESPA1 | TET1 | TET2 | TET2-AS1 | TET3 | Tetraspanin | TEX10 | TEX101 | TEX11 | TEX12 | TEX13A | TEX13B | TEX13C | TEX14 | TEX15 | TEX19 | TEX2 | TEX21P | TEX22 | TEX26 | TEX261 | TEX264 | TEX28 | TEX29 | TEX30 | TEX33 | TEX35 | TEX36 | TEX36-AS1 | TEX37 | TEX38 | TEX41 | TEX43 | TEX44 | TEX45 | TEX46 | TEX47 | TEX48 | TEX49 | TEX50 | TEX52 | TEX53 | TEX55 | TEX56P | TEX9 | TF | TFAM | TFAMP1 | TFAP2A | TFAP2A-AS1 | TFAP2A-AS2 | TFAP2B | TFAP2C | TFAP2D | TFAP2E | TFAP4 | TFB1M | TFB2M | TFCP2 | TFCP2L1 | TFDP1 | TFDP1P2 | TFDP2 | TFDP3 | TFE3 | TFEB | TFEC | TFF1 | TFF2 | TFF3 | TFG | TFIID Basal Transcription Factor Complex | TFIIIC2 complex | TFIP11 | TFIP11-DT | TFPI | TFPI2 | TFPT | TFR2 | TFRC | TG | TGDS | TGFA | TGFA-IT1 | TGFB1 | TGFB1I1 | TGFB2 | TGFB2-AS1 | TGFB3